Ignite Creation Date:
2025-12-24 @ 11:02 PM
Ignite Modification Date:
2026-05-14 @ 2:48 PM
Study NCT ID:
NCT06041269
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-11-25
First Post:
2023-09-11
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Efficacy and Safety of Rosnilimab in Subjects with Moderate to Severe Rheumatoid Arthritis (RENOIR)
Sponsor:
AnaptysBio, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
ANB030-203
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None